Form 4: Acumen Pharmaceuticals Chief Medical Officer Sells Shares to Cover Tax Obligations

Eric Siemers, Chief Medical Officer of Acumen Pharmaceuticals, sold 3,219 shares of common stock on January 21, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On January 21, 2025, Eric Siemers, the Chief Medical Officer of Acumen Pharmaceuticals, sold 3,219 shares of the company's common stock.
• The sale was executed at a price of $1.59 per share.
• This transaction was conducted to satisfy tax withholding obligations associated with the vesting of restricted stock units.
• The sale was executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted on September 3, 2024.
• Following the transaction, Siemers directly owns 170,298 shares of Acumen Pharmaceuticals.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although it is a common practice for covering tax obligations.

Key Dates

Keywords

Acumen Pharmaceuticals, ABOS, Eric Siemers, Chief Medical Officer, Stock Sale, Form 4, Rule 10b5-1, Restricted Stock Units, Tax Withholding, Beneficial Ownership